Clinical Trial Update: Cystagon to Treat Infantile Neuronal Ceroid Lipofuscinosis [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial investigated the use of Cystagon (cysteamine bitartrate) to treat infantile neuronal ceroid lipofuscinosis; results were posted afte…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infantile Neuronal Ceroid Lipofuscinosis

Drugs mentioned

• Cystagon (cysteamine bitartrate)

Snippet

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Conditions: Infantile Neronal Ceroid Lipofuscinosis | Phase 4 | Status: COMPLETED | Results posted: 2015-01-21